Investors make money with Bioverge by investing in startups. After an investment is made in a startup, the investor holds private equity in that company. The value of the investment will either increase or decrease based on how the company performs. Investors receive cash or stock if and when a positive liquidity event occurs.

Bioverge makes their money by collecting 6% of the total amount raised from the startup and 2% of the securities that are offered in a successful financing.

Investing in private equity means that the securities are not publicly traded. This means that they are subject to holding period requirements and should only be invested in by investors who do not need a liquid investment. Investments in private companies are highly speculative and come with a high degree of risk. This risk can include the loss of the investment.